Skip to main navigation
logo
  • About Us
    • Board of Directors
    • Management
  • Our Science
    • Oncolytic Immunotherapy
    • The Immulytic Platform
  • Pipeline
  • Investors and Media
    • Overview
    • Events and Presentations
    • Press Releases
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Publications
    • Email Alerts
    • Investor Contact
  • Careers
  • Contact
Select Page

SEC Filing Details

SEC Filing Details

Document Details

Form
SC 13G
Filing Date
Aug 1, 2018
Document Date
Aug 1, 2018
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
3,4,5
Company
Replimune
Issuer
Replimune Group, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
RSS Feeds RSS Feeds
Email Alerts Email Alerts
Contact IR Contact IR
Search Search

© 2018 Replimune Group Inc
18 Commerce Way, Woburn, MA 01801 Privacy | Terms